Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 11, 2006, Pages 3859-3864

  Vicini, Paola ^a   Geronikaki, Athina ^b   Anastasia, Kitka ^b   Incerti, Matteo ^a   Zani, Franca ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

2 Thiazolylimino 5 arylidene 4 thiazolidinones; Antimicrobial activity; Thiazole derivatives; Thiazolidinone derivatives

Indexed keywords

2 (THIAZOL 2 YLIMINO)THIAZOLIDIN 4 ONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; 4 THIAZOLIDINONE DERIVATIVE; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZENE; CHLORINE DERIVATIVE; GLYCERYL TRINITRATE; HYDROXYL GROUP; MICONAZOLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOULD; NONHUMAN; STAPHYLOCOCCUS; STRUCTURE ACTIVITY RELATION; YEAST;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STRUCTURE-ACTIVITY RELATIONSHIP; THIAZOLES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FUNGI; HAEMOPHILUS INFLUENZAE; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS;

EID: 33646071514     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.01.043     Document Type: Article

References (30)

1. Tenover F.C., and McDonald L.C. Curr. Opin. Infect. Dis. 18 (2005) 300
2. Pfeltz R.F., and Wilkinson B.J. Curr. Drug Targets Infect. Disord. 4 (2004) 273
3. Roberts M.C. Curr. Drug Targets Infect. Disord. 4 (2004) 207
4. Dessen A., Di Guilmi A.M., Vernet T., and Dideberg O. Curr. Drug Targets Infect. Disord. 1 (2001) 63
5. Muroi H., Nihei K., Tsujimoto K., and Kubo I. Bioorg. Med. Chem. 12 (2004) 583
6. Khan M.W., Alam M.J., Rashid M.A., and Chowdhury R. Bioorg. Med. Chem. 13 (2005) 4796
7. Torres-Viera C., and Dembry L.M. Curr. Opin. Infect. Dis. 17 (2004) 541
8. Anstead G.M., and Owens A.D. Curr. Opin. Infect. Dis. 17 (2004) 549
9. Ford C.W., Zurenko G.E., and Barbachyn M.R. Curr. Drug Targets Infect. Disord. 1 (2001) 181
10. Zani F., and Vicini P. Arch. Pharm. Pharm. Med. Chem. 331 (1998) 219
11. Vicini P., and Zani F. Il Farmaco 52 (1997) 21
12. Vicini P., and Mazza P. Il Farmaco 44 (1989) 511
13. Vicini P., Zani F., Cozzini P., and Doytchinova I. Eur. J. Med. Chem. 37 (2002) 553
14. Zani F., Vicini P., and Incerti M. Eur. J. Med. Chem. 39 (2004) 135
15. Turan-Zitouni G., Demirayak S., Ozdemir A., Kaplancikli Z.A., and Yildiz M.T. Eur. J. Med. Chem. 39 (2004) 267
16. Geronikaki A., Dearden J., Filimonov D., Galaeva I., Garibova T.L., Gloriozova T., Krajneva V., Lagunin A., Macaev F.Z., Molodavkin G., Poroikov V.V., Pogrebnoi S.I., Shepeli F., Voronina T.A., Tsitlakidou M., and Vlad L. J. Med. Chem. 47 (2004) 2870
17. Geronikaki A., Babaev E., Dearden J., Dehaen W., Filimonov D., Galaeva I., Krajneva V., Lagunin A., Macaev F., Molodavkin G., Poroikov V., Pogrebnoi S., Saloutin V., Stepanchikova A., Stingaci E., Tkach N., Vlad L., and Voronina T. Bioorg. Med. Chem. 12 (2004) 6559
18. Tsutsumi S., Okonogi T., Shibahara S., Ohuchi S., Hatsushiba E., Patchett A.A., and Christensen B.G. J. Med. Chem. 37 (1994) 3492
19. Chen P., Norris D., Das J., Spergel S.H., Wityak J., Leith L., Zhao R., Chen B., Pitt S., Pang S., Shen D.R., Zhang R., De Fex H.F., Doweyko A.M., McIntyre K.W., Shuster D.J., Behnia K., Schieven G.L., and Barrish J.C. Bioorg. Med. Chem. Lett. 14 (2004) 6061
20. Kucukguzel S.G., Oruc E.E., Rollas S., Sahin F., and Ozbek A. Eur. J. Med. Chem. 37 (2002) 197
21. Srivastava S.K., Srivastava S., and Srivastava S.D. Ind. J. Chem. 41B 9 (2002) 2357 Section B
22. Abbas S.E., Hanna M.M., Abou Sier A.H., and Ramadan M.A. Egypt J. Pharm. Sci. 34 (1993) 195
23. Singh S., Parmar S., Raman K., and Stenberg V. Chem. Rev. 81 (1981) 175
24. Vicini P., Fisicaro E., and Lugari M.T. Arch. Pharm. Pharm. Med. Chem. 333 (2000) 135
25. Geronikaki A., and Theophilidis G. Eur. J. Med. Chem. 27 (1992) 709
26. Cesur Z. Pharmazie 11 (1987) 716
27. Ottanà R., Maccari R., Barreca M.L., Bruno G., Rotondo A., Rossi A., Chiricosta G., Di Paola R., Sautebin L., Cuzzocrea S., and Vigorita M.G. Bioorg. Med. Chem. 13 (2005) 4243
28. Bruno G., Costantino L., Curinga C., Maccari R., Monforte F., Nicolò F., Ottanà R., and Vigorita M.G. Bioorg. Med. Chem. 10 (2002) 1077
29. Bacchi A., Carcelli M., Pelizzi G., and Vicini P. Arch. Pharm. 328 (1995) 217
30. Jorgensen J.H., et al. Antimicrobial agents and susceptibility testing, Section X. In: Tonover F.C. (Ed). Clinical Microbiology (1995), ASM Press, Washington, DC 1275-1434